↓ Skip to main content

Low- versus Mid-frequency Raman Spectroscopy for in Situ Analysis of Crystallization in Slurries

Overview of attention for article published in Molecular Pharmaceutics, May 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Low- versus Mid-frequency Raman Spectroscopy for in Situ Analysis of Crystallization in Slurries
Published in
Molecular Pharmaceutics, May 2022
DOI 10.1021/acs.molpharmaceut.2c00126
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 3 17%
Other 2 11%
Student > Master 2 11%
Lecturer > Senior Lecturer 1 6%
Student > Doctoral Student 1 6%
Other 3 17%
Unknown 6 33%
Readers by discipline
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Chemistry 2 11%
Chemical Engineering 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Earth and Planetary Sciences 1 6%
Other 3 17%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2022.
All research outputs
#21,285,712
of 26,017,215 outputs
Outputs from Molecular Pharmaceutics
#3,280
of 4,633 outputs
Outputs of similar age
#337,289
of 448,655 outputs
Outputs of similar age from Molecular Pharmaceutics
#76
of 113 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,633 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,655 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.